TOYO Co., Ltd Announces Leadership Transition
TOKYO, March 18, 2026 /PRNewswire/ -- TOYO Co., Ltd (Nasdaq: TOYO) (OTC: TOYWF), ("TOYO" or the "Company"), a solar solution company, today announced a planned leadership transition and the strengthening of its executive team to support the...
Lasfit Announces One of the First Custom-Fit Floor Mats Designed for 2026 Toyota RAV4
LOS ANGELES, March 18, 2026 /PRNewswire/ -- Today, Lasfit announced the launch of one of the first custom-fit floor mat solutions designed specifically for 2026 Toyota RAV4.The new interior protection kit, which offers extended coverage to help...
COSCO SHIPPING Ports Announces 2025 Annual Results
Connecting Points to Build Networks Reaching New Horizons through Digital Intelligence HONG KONG, March 18, 2026 /PRNewswire/ -- COSCO SHIPPING Ports Limited ("COSCO SHIPPING Ports" or "CSP" or the "Company", SEHK: 1199), the world's leading ports...
TENCENT ANNOUNCES 2025 ANNUAL AND FOURTH QUARTER RESULTS
AI Strengthened Existing Core Businesses Increasing Investments and Upgrading AI Capabilities to Capture New Opportunities HONG KONG, March 18, 2026 /PRNewswire/ -- Tencent Holdings Limited (HKEX: 00700 (HKD Counter) and 80700 (RMB Counter),...
Weibo Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results and Annual Dividend
BEIJING, March 18, 2026 /PRNewswire/ -- Weibo Corporation ("Weibo" or the "Company") (Nasdaq: WB and HKEX: 9898), a leading social media in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December...
Oral Small Molecule Amylin Receptor Agonist ASC39 Demonstrated Eloralintide-like Amylin Selectivity and Efficacy in Preclinical Models
- In a head-to-head cyclic adenosine monophosphate (cAMP) activation assay vs. eloralintide, oral small molecule amylin receptor agonist ASC39 demonstrated similar selectivity and potency to that of eloralintide. EC 50 for human amylin 1 receptor...
Celltrion announces U.S. availability of AVTOZMA® (tocilizumab-anoh) subcutaneous (SC) formulation
AVTOZMA ® (tocilizumab-anoh) is among the first wave of tocilizumab biosimilars with both intravenous (IV) and subcutaneous (SC) formulations approved and commercially available in the United States The launch of AVTOZMA SC further diversifies...
SKF announces new business segments and releases restated figures
GOTHENBURG, Sweden, March 16, 2026 /PRNewswire/ -- SKF today announces the introduction of a new segment reporting structure, effective from Q1 2026. The purpose of these changes is to reflect the Group's strategic focus and to provide increased...
EBANX announces HQ in Singapore and forecasts a 30% growth for APAC merchants in 2026
Global technology company integrates local payment methods across emerging markets in Latin America, Africa, and Asia for more than 100 APAC enterprise merchants 36% of EBANX's TPV last year came from APAC companies, which will have a technology and...
NYSE Content Update: AT&T CEO John Stankey to Ring Bell on 150th Anniversary of First Phone Call
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 10, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE...